The efficacy and safety of strontium ranelate in the treatment of male osteoporosis: a prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year

Not Applicable

Completed

• Conditions: Male osteoporosis; Musculoskeletal Diseases; Osteoporosis

• Registration Number: ISRCTN49960746
• Lead Sponsor: Institut de Recherches Internationales Servier (France)

Brief Summary

2013 results in https://www.ncbi.nlm.nih.gov/pubmed/23341486

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-11-30
• Study Completion: 2011-02-28
• Last Update Posted: 30 April 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 221

Inclusion Criteria

1. Caucasian males of at least 65 years of age
2. Osteoporosis

Exclusion Criteria

1. BMD T-score less than -4.0
2. More than two prevalent mild and/or moderate osteoporotic vertebral fractures
3. Severe osteoporotic vertebral fractures

Study & Design

• Study Type: Interventional
• Study Design: Not specified